Fibrinolytic therapy for parapneumonic empyema during pregnancy
Fibrinolytic therapy for parapneumonic empyema during pregnancy
复制标题
DOI：
10.1016/j.rmedc.2011.08.005
复制
发表时间：
2012-01-01
影响因子：
1.1
通讯作者：
Kuzucu, Akin
中科院分区：
文献类型：
--
作者：
Ulutas, Hakki;Yekeler, Erdal;Kuzucu, Akin
妊娠期肺炎及旁淋巴管积液并不常见，但对母亲和胎儿都有潜在的严重风险。酶清创胸膜腔与纤溶药物是一种非侵入性的选择，可以促进引流，并避免手术的需要。在此，我们描述了两例妊娠妇女的胸膜旁脓胸谁是成功地治疗胸膜内纤溶治疗。(C)2011 Elsevier Ltd.
Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Herein, we describe the cases of two pregnant women with parapneumonic empyema who were successfully treated with intrapleural fibrinolytic therapy. (C) 2011 Elsevier Ltd.